Commit Biologics ApS is a Danish APS based in Aarhus C, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2021, the company has 23 employees and reported a gross profit of -DKK 23.4m in its latest annual filing.
EBITDA margin (of gross profit) 167.8 %
+13% vs 2024
Solidity ratio Equity ÷ Total assets × 100 Among the 20% highest rated companies in the industry
2022 2025
Liquidity ratio Current assets ÷ Short-term debt Among the 10% highest rated companies in the industry
2022 2025
Return on assets (ROA) Net profit ÷ Total assets × 100 Among the 10% lowest rated companies in the industry
2022 2025
EBITDA — year on year DKK millions 0M -14M -28M -42M -56M 2022: -4M -4M 2022 2023: -21M (-425% vs 2022) -21M -425% 2023 2024: -45M (-114% vs 2023) -45M -114% 2024 2025: -39M (+13% vs 2024) -39M +13% 2025
Key figures Annual report 2025 Gross profit -23.4M DKK -26% EBITDA -39.2M DKK +13% Net profit -33.8M DKK +14% Total assets 38.8M DKK +59% Equity 37.9M DKK +63% Employees 23 —
Legal name
Commit Biologics ApS
Founded
1 September 2021 · 4 years
Financial year
January – December
Signatory rights
Selskabet tegnes af to bestyrelsesmedlemmer i forening eller af et bestyrelsesmedlem i forening med en direktør eller af den samlede bestyrelse.
Company purpose
Selskabets formål er fremstilling af farmaceutiske præparater, forskning og eksperimentel udvikling indenfor bioteknologi.
(no translation available)
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.comExplore Companies in Research and experimental development on natural sciences and engineering Companies in Aarhus All Denmark companiesFinancial development In its most recent annual report (2025), Commit Biologics ApS reported a gross profit of -DKK 23.4m. The figures on this page draw on 4 annual filings covering 2022 to 2025. The bottom line showed a net loss of DKK 33.8m.
At the end of 2025, equity financed 97.7% of the balance sheet, and current assets covered short-term debt 40.1 times. Commit Biologics ApS is one of 2 companies registered under Research and experimental development on natural sciences and engineering in Denmark.
Frequently asked questions What is the CVR number of Commit Biologics ApS? Commit Biologics ApS is registered with CVR / Virk under CVR 42642649.
What is the gross profit of Commit Biologics ApS? Commit Biologics ApS reported a gross profit of -DKK 23.4m in 2025.
How many employees does Commit Biologics ApS have? Commit Biologics ApS employs 23 people as of the latest annual report.
Who is the CEO of Commit Biologics ApS? Thomas Lars Andresen is the CEO of Commit Biologics ApS, in role since 2026.
Who is the chairman of Commit Biologics ApS? Anker Gunvald Lundemose chairs the board of Commit Biologics ApS, in role since 2023.
Where is Commit Biologics ApS headquartered? Commit Biologics ApS's registered address is Universitetsbyen 81.
More on Commit Biologics ApS